Copiktra

Generic name:duvelisib [ DOO-ve-LIS-ib ]
Drug class:PI3K inhibitors

Medically reviewed by Judith Stewart, BPharm. Last updated on May 18, 2022.

What is Copiktra?

Copiktra is a prescription medicine used to treat adults with chronic lymphocytic leukemia or small lymphocytic leukemia.

Copiktra is given after at least two other cancer treatments did not work or have stopped working.

It is not known if Copiktra is safe and effective in children less than 18 years of age.

Warnings

Copiktra can cause serious or fatal side effects, including serious infections, severe diarrhea, or a life-threatening skin rash.

Call your doctor right away if you have symptoms such as:

• fever, chills, cough, breathing problems;

• severe stomach pain, diarrhea with blood or mucus; o

• painful mouth sores, or a skin rash with blistering or peeling.

Before taking this medicine

To make sure Copiktra is safe for you, tell your doctor if you have ever had:

• an intestinal disorder such as ulcerative colitis;

• lung disease; or

• liver disease.

Both men and women using this medicine should use effective birth control to prevent pregnancy. Duvelisib can harm an unborn baby or cause birth defects if the mother or father is using this medicine.

Keep using birth control for at least 1 month after your last dose. Tell your doctor right away if a pregnancy occurs while either the mother or the father is using Copiktra.

It is not safe to breast-feed a baby while you are using duvelisib. A...